Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy

Completed · Phase 3

Conditions studied: Radiculopathy

In brief

Trial will evaluate the efficacy and safety of pregabalin in the treatment of subjects with neuropathic pain associated with lumbo-sacral radiculopathy.

Key facts

Study ID

NCT00159705

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

276

Starts

2005-04-01

Expected to finish

2007-06-01

Last updated by the study team

2021-01-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pain consistent with a diagnosis of chronic lumbo-sacral radiculopathy due to spinal stenosis or disk herniation.
• Radicular pain must be present for at least 3 months and pain stable for at least 4 weeks.

You may not qualify if…

• Surgery for lumbo-sacral radiculopathy within previous 6 months and/or more than one previous spinal surgery for pain-radiculopathy.
• Epidural injection for lumbo-sacral radiculopathy within previous 6 weeks and/or anticipated need for treatment with opioid analgesics, anti-epileptic medications or tricyclic antidepressants to alleviate pain due to lumbo-sacral radiculopathy during the course of the study.

Where it is running

• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Plantation, Florida, United States
• Pfizer Investigational Site — Chicago, Illinois, United States
• Pfizer Investigational Site — Indianapolis, Indiana, United States
• Pfizer Investigational Site — Boston, Massachusetts, United States
• Pfizer Investigational Site — Independence, Missouri, United States
• Pfizer Investigational Site — Rochester, New York, United States
• Pfizer Investigational Site — Valley Stream, New York, United States
• Pfizer Investigational Site — Portland, Oregon, United States
• Pfizer Investigational Site — Allentown, Pennsylvania, United States
• Pfizer Investigational Site — Allentown, Pennsylvania, United States
• Pfizer Investigational Site — Bethlehem, Pennsylvania, United States
• Pfizer Investigational Site — Edegem, Belgium
• Pfizer Investigational Site — Eeklo, Belgium
• Pfizer Investigational Site — Genk, Belgium
• Pfizer Investigational Site — Pellenberg, Belgium
• Pfizer Investigational Site — Vancouver, British Columbia, Canada
• Pfizer Investigational Site — Hawkesbury, Ontario, Canada
• Pfizer Investigational Site — Kingston, Ontario, Canada
• Pfizer Investigational Site — London, Ontario, Canada
• Pfizer Investigational Site — Toronto, Ontario, Canada
• Pfizer Investigational Site — Fleurimont, Quebec, Canada
• Pfizer Investigational Site — Montreal, Quebec, Canada
• Pfizer Investigational Site — Bremen, Germany
• Pfizer Investigational Site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.